Primary Site >> Liver Cancer
Gene >> MAD2L1
| 1. | |||||||||||
| Journal: | Int J Cancer. 2001 Jul 20;95(4):223-7. | ||||||||||
| Title: | Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. | ||||||||||
| Author: | Hernando, E|Orlow, I|Liberal, V|Nohales, G|Benezra, R|Cordon-Cardo, C | ||||||||||
| PMID: | 11400114 | ||||||||||
| 2. | |||||||||||
| Journal: | Jpn J Cancer Res. 2001 Sep;92(9):952-8. | ||||||||||
| Title: | Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. | ||||||||||
| Author: | Tanaka, K|Nishioka, J|Kato, K|Nakamura, A|Mouri, T|Miki, C|Kusunoki, M|Nobori, T | ||||||||||
| PMID: | 11572763 | ||||||||||
| 3. | |||||||||||
| Journal: | BMC Infect Dis. 2009 Aug 10;9:125. | ||||||||||
| Title: | Modulations of cell cycle checkpoints during HCV associated disease. | ||||||||||
| Author: | Sarfraz, Saira|Hamid, Saeed|Ali, Syed|Jafri, Wasim|Siddiqui, Anwar A | ||||||||||
| PMID: | 19664251 | ||||||||||
| 4. | |||||||||||
| Journal: | Eur Rev Med Pharmacol Sci. 2015 Feb;19(4):592-601. | ||||||||||
| Title: | Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. | ||||||||||
| Author: | Jin, B|Wang, W|Du, G|Huang, G-Z|Han, L-T|Tang, Z-Y|Fan, D-G|Li, J|Zhang, S-Z | ||||||||||
| PMID: | 25753876 | ||||||||||
| 5. | |||||||||||
| Journal: | Pathol Res Pract. 2017 Apr;213(4):316-321. | ||||||||||
| Title: | Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. | ||||||||||
| Author: | Yan, Hongxian|Li, Zhaohui|Shen, Quan|Wang, Qian|Tian, Jianguo|Jiang, Qingfeng|Gao, Linbo | ||||||||||
| PMID: | 28238542 | ||||||||||
| 6. | |||||||||||
| Journal: | Elife. 2017 Mar 20;6. | ||||||||||
| Title: | Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma. | ||||||||||
| Author: | Foijer, Floris|Albacker, Lee A|Bakker, Bjorn|Spierings, Diana C|Yue, Ying|Xie, Stephanie Z|Davis, Stephanie|Lutum-Jehle, Annegret|Takemoto, Darin|Hare, Brian|Furey, Brinley|Bronson, Roderick T|Lansdorp, Peter M|Bradley, Allan|Sorger, Peter K | ||||||||||
| PMID: | 28318489 | ||||||||||
| 7. | |||||||||||
| Journal: | Biomed Pharmacother. 2017 Aug;92:1038-1044. | ||||||||||
| Title: | MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1. | ||||||||||
| Author: | Li, Yuanhang|Bai, Weijun|Zhang, Jianjun | ||||||||||
| PMID: | 28609841 | ||||||||||
| 8. | |||||||||||
| Journal: | Med Sci Monit. 2018 May 5;24:2786-2808. | ||||||||||
| Title: | Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction. | ||||||||||
| Author: | Wen, Dong-Yue|Lin, Peng|Pang, Yu-Yan|Chen, Gang|He, Yun|Dang, Yi-Wu|Yang, Hong | ||||||||||
| PMID: | 29728556 | ||||||||||
| 9. | |||||||||||
| Journal: | Cancer Cell Int. 2018 Sep 17;18:140. | ||||||||||
| Title: | DNA methylation biomarkers for hepatocellular carcinoma. | ||||||||||
| Author: | Fan, Guorun|Tu, Yaqin|Chen, Cai|Sun, Haiying|Wan, Chidan|Cai, Xiong | ||||||||||
| PMID: | 30245591 | ||||||||||
| 10. | |||||||||||
| Journal: | Biosci Rep. 2018 Oct 19. pii: BSR20181441. | ||||||||||
| Title: | Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma. | ||||||||||
| Author: | Gao, Xueren|Wang, Xixi|Zhang, Shulong | ||||||||||
| PMID: | 30341252 | ||||||||||
| 11. | |||||||||||
| Journal: | Biomed Res Int. 2018 Sep 30;2018:7897346. | ||||||||||
| Title: | Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients. | ||||||||||
| Author: | Zhuang, Liping|Yang, Zongguo|Meng, Zhiqiang | ||||||||||
| PMID: | 30363964 | ||||||||||